These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23269586)

  • 21. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
    Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
    Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
    Kim J; Kim SJ; Chang YS; Park WS
    Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
    Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
    Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parameters affecting postoperative success of surgery for stage 4A/4B ROP.
    Özsaygili C; Ozdek S; Ozmen MC; Atalay HT; Yalinbas Yeter D
    Br J Ophthalmol; 2019 Nov; 103(11):1624-1632. PubMed ID: 30658990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and outcomes of anterior hyaloidal fibrovascular proliferation in lasered retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Study (ITCROPS) report number 4.
    Dave VP; Jalali S; Rani PK; Padhi TR
    Int Ophthalmol; 2014 Jun; 34(3):511-7. PubMed ID: 24037522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).
    Wutthiworawong B; Thitiratsanont U; Saovaprut C; Subhangkasen I; Geyuraphun B; Ampornprut A; Phumongkutchai J; Tephusdinnaayuthaya S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S15-21. PubMed ID: 22043749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose versus conventional dose of intravitreal bevacizumab injection for retinopathy of prematurity: a case series with paired-eye comparison.
    Han J; Kim SE; Lee SC; Lee CS
    Acta Ophthalmol; 2018 Jun; 96(4):e475-e478. PubMed ID: 27011262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.
    Futamura Y; Asami T; Nonobe N; Kachi S; Ito Y; Sato Y; Hayakawa M; Terasaki H
    Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP).
    Repka MX; Tung B; Good WV; Shapiro M; Capone A; Baker JD; Barr CC; Phelps DL; van Heuven WA
    Arch Ophthalmol; 2006 Jan; 124(1):24-30. PubMed ID: 16401781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.
    Toy BC; Schachar IH; Tan GS; Moshfeghi DM
    Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.
    Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity.
    Quiroz-Mercado H; Martinez-Castellanos MA; Hernandez-Rojas ML; Salazar-Teran N; Chan RV
    Retina; 2008 Mar; 28(3 Suppl):S19-25. PubMed ID: 18317339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomical and refractive outcomes in patients with treated retinopathy of prematurity.
    Lolas M; Tuma A; Zanolli M; Agurto R; Stevenson R; Ossandón D
    Arch Soc Esp Oftalmol; 2017 Oct; 92(10):472-476. PubMed ID: 28624314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection.
    Xu Y; Zhang Q; Kang X; Zhu Y; Li J; Chen Y; Zhao P
    Acta Ophthalmol; 2013 Jun; 91(4):e304-10. PubMed ID: 23647944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity.
    Azuma N; Ito M; Yokoi T; Nakayama Y; Nishina S
    JAMA Ophthalmol; 2013 Oct; 131(10):1309-13. PubMed ID: 23990065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of intravitreal bevacizumab for the treatment of retinopathy of prematurity: a single-center retrospective review.
    Frosini S; Franco F; Vicini G; Nicolosi C; Varriale G; Dani C; Virgili G; Giansanti F
    J Matern Fetal Neonatal Med; 2022 Sep; 35(17):3337-3342. PubMed ID: 32933350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.
    Roohipoor R; Ghasemi H; Ghassemi F; Karkhaneh R; Riazi-Esfahani M; Nili-Ahmadabadi M
    Graefes Arch Clin Exp Ophthalmol; 2011 Sep; 249(9):1295-301. PubMed ID: 21494873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?
    Dikci S; Ceylan OM; Demirel S; Yılmaz T
    Arq Bras Oftalmol; 2018; 81(1):12-17. PubMed ID: 29538588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.